Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytokinetics, Incorporated - Common Stock
(NQ:
CYTK
)
65.06
+2.86 (+4.60%)
Streaming Delayed Price
Updated: 12:01 PM EST, Nov 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cytokinetics, Incorporated - Common Stock
< Previous
1
2
3
4
5
Next >
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Today 12:00 EST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Today 12:00 EST
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies Shareholders of Cytokinetics, Incorporated (CYTK) of a Class Action Lawsuit and an Upcoming Deadline
Today 9:15 EST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Levi & Korsinsky Notifies Shareholders of Cytokinetics, Incorporated (CYTK) of a Class Action Lawsuit and an Upcoming Deadline
Today 9:15 EST
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Cytokinetics, Quanex, RCI, and Fortinet to Contact the Firm About their Rights
November 10, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
November 10, 2025
From
Schall Law
Via
GlobeNewswire
Investors Who Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi & Korsinsky About Pending Class Action - CYTK
November 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Investors Who Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi & Korsinsky About Pending Class Action - CYTK
November 10, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 09, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 09, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit
November 09, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
November 17, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CYTK
November 07, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
November 17, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CYTK
November 07, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Cytokinetics
November 06, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
November 06, 2025
From
Schall Law
Via
GlobeNewswire
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
November 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
November 06, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
November 05, 2025
From
SkyMedia, LLC
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK
November 05, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Cytokinetics, Incorporated Class Action: Levi & Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
November 05, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Cytokinetics, Incorporated Class Action: Levi & Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
November 05, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
November 04, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders
November 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders
November 04, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
November 04, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 04, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
CYTOKINETICS CLASS ACTION: Bragar Eagel & Squire, P.C. Urges Cytokinetics Stockholders to Contact the Firm Regarding Their Rights Before November 17th
November 03, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
November 03, 2025
From
Schall Law
Via
GlobeNewswire
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
October 31, 2025
From
Schall Law
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.